BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

263 related articles for article (PubMed ID: 31817853)

  • 21. ETV6/RUNX1-positive childhood acute lymphoblastic leukemia in China: excellent prognosis with improved BFM protocol.
    Wang Y; Zeng HM; Zhang LP
    Ital J Pediatr; 2018 Aug; 44(1):94. PubMed ID: 30115129
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Pathogenesis of ETV6/RUNX1-positive childhood acute lymphoblastic leukemia and mechanisms underlying its relapse.
    Sun C; Chang L; Zhu X
    Oncotarget; 2017 May; 8(21):35445-35459. PubMed ID: 28418909
    [TBL] [Abstract][Full Text] [Related]  

  • 23. ETV6/RUNX1 induces reactive oxygen species and drives the accumulation of DNA damage in B cells.
    Kantner HP; Warsch W; Delogu A; Bauer E; Esterbauer H; Casanova E; Sexl V; Stoiber D
    Neoplasia; 2013 Nov; 15(11):1292-300. PubMed ID: 24339741
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Simultaneous occurrence of ETV6-RUNX1 and BCR-ABL1 (e1a2) transcripts in a child with B-cell acute lymphoblastic leukemia.
    Balatzenko G; Guenova M; Kalinova I; Belcheva M; Hristozova H; Kaleva V
    Cancer Genet; 2013 Mar; 206(3):97-101. PubMed ID: 23491079
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Genetic alterations in glucocorticoid signaling pathway components are associated with adverse prognosis in children with relapsed ETV6/RUNX1-positive acute lymphoblastic leukemia.
    Grausenburger R; Bastelberger S; Eckert C; Kauer M; Stanulla M; Frech C; Bauer E; Stoiber D; von Stackelberg A; Attarbaschi A; Haas OA; Panzer-Grümayer R
    Leuk Lymphoma; 2016 May; 57(5):1163-73. PubMed ID: 26327566
    [TBL] [Abstract][Full Text] [Related]  

  • 26. ETV6/RUNX1-like acute lymphoblastic leukemia: A novel B-cell precursor leukemia subtype associated with the CD27/CD44 immunophenotype.
    Zaliova M; Kotrova M; Bresolin S; Stuchly J; Stary J; Hrusak O; Te Kronnie G; Trka J; Zuna J; Vaskova M
    Genes Chromosomes Cancer; 2017 Aug; 56(8):608-616. PubMed ID: 28395118
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Differential impact of drugs on the outcome of ETV6-RUNX1 positive childhood B-cell precursor acute lymphoblastic leukaemia: results of the EORTC CLG 58881 and 58951 trials.
    Piette C; Suciu S; Clappier E; Bertrand Y; Drunat S; Girard S; Yakouben K; Plat G; Dastugue N; Mazingue F; Grardel N; van Roy N; Uyttebroeck A; Costa V; Minckes O; Sirvent N; Simon P; Lutz P; Ferster A; Pluchart C; Poirée M; Freycon C; Dresse MF; Millot F; Chantrain C; van der Werff Ten Bosch J; Norga K; Gilotay C; Rohrlich PS; Benoit Y; Cavé H
    Leukemia; 2018 Jan; 32(1):244-248. PubMed ID: 29064485
    [No Abstract]   [Full Text] [Related]  

  • 28. Minimal residual disease monitoring in childhood B lymphoblastic leukemia with t(12;21)(p13;q22); ETV6-RUNX1: concordant results using quantitation of fusion transcript and flow cytometry.
    Alm SJ; Engvall C; Asp J; Palmqvist L; Abrahamsson J; Fogelstrand L
    Int J Lab Hematol; 2017 Apr; 39(2):121-128. PubMed ID: 28004528
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Role of the erythropoietin receptor in ETV6/RUNX1-positive acute lymphoblastic leukemia.
    Inthal A; Krapf G; Beck D; Joas R; Kauer MO; Orel L; Fuka G; Mann G; Panzer-Grümayer ER
    Clin Cancer Res; 2008 Nov; 14(22):7196-204. PubMed ID: 19010836
    [TBL] [Abstract][Full Text] [Related]  

  • 30. RUNX1 aberrations in ETV6/RUNX1-positive and ETV6/RUNX1-negative patients: its hemato-pathological and prognostic significance in a large cohort (619 cases) of ALL.
    Pais AP; Amare Kadam PS; Raje GC; Banavali S; Parikh P; Kurkure P; Arora B; Gujral S; Kumar SA; Badrinath Y
    Pediatr Hematol Oncol; 2008 Sep; 25(6):582-97. PubMed ID: 18728978
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Therapeutic potential of spleen tyrosine kinase inhibition for treating high-risk precursor B cell acute lymphoblastic leukemia.
    Perova T; Grandal I; Nutter LM; Papp E; Matei IR; Beyene J; Kowalski PE; Hitzler JK; Minden MD; Guidos CJ; Danska JS
    Sci Transl Med; 2014 May; 6(236):236ra62. PubMed ID: 24828076
    [TBL] [Abstract][Full Text] [Related]  

  • 32. A Double Negative Loop Comprising ETV6/RUNX1 and MIR181A1 Contributes to Differentiation Block in t(12;21)-Positive Acute Lymphoblastic Leukemia.
    Yang YL; Yen CT; Pai CH; Chen HY; Yu SL; Lin CY; Hu CY; Jou ST; Lin DT; Lin SR; Lin SW
    PLoS One; 2015; 10(11):e0142863. PubMed ID: 26580398
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Prevalence of ETV6-RUNX1 fusion gene in children with acute lymphoblastic leukemia in China.
    Gao YJ; Zhu XH; Yang Y; Wu Y; Lu FJ; Zhai XW; Wang HS
    Cancer Genet Cytogenet; 2007 Oct; 178(1):57-60. PubMed ID: 17889709
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Scaffold hopping of the SYK inhibitor entospletinib leads to broader targeting of the BCR signalosome.
    Jorda R; Krajčovičová S; Králová P; Soural M; Kryštof V
    Eur J Med Chem; 2020 Oct; 204():112636. PubMed ID: 32731189
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Fishing for ETV6/RUNX1 fusion and MLL gene rearrangements and their additional abnormalities in childhood acute lymphoblastic leukemia patients of Kashmir.
    Mohiuddin Malla T; Amin Shah Z; Hussain Bhat A; Ahmad Malik M; Anjum Baba R; Rasool R; Rasool J; Ashaq S; Haq F
    Gene; 2023 Mar; 856():147128. PubMed ID: 36565795
    [TBL] [Abstract][Full Text] [Related]  

  • 36. ETV6-RUNX1 and RUNX1 directly regulate RAG1 expression: one more step in the understanding of childhood B-cell acute lymphoblastic leukemia leukemogenesis.
    Jakobczyk H; Jiang Y; Debaize L; Soubise B; Avner S; Sérandour AA; Rouger-Gaudichon J; Rio AG; Carroll JS; Raslova H; Gilot D; Liu Z; Demengeot J; Salbert G; Douet-Guilbert N; Corcos L; Galibert MD; Gandemer V; Troadec MB
    Leukemia; 2022 Feb; 36(2):549-554. PubMed ID: 34535762
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Newly diagnosed ETV6-RUNX1-positive B-acute lymphoblastic leukemia localized to the left pelvic bone marrow.
    Baba M; Imamura M; Imai C
    Int J Hematol; 2022 Feb; 115(2):151-152. PubMed ID: 34981432
    [No Abstract]   [Full Text] [Related]  

  • 38. [Clinical significance of monitoring ETV6-RUNX1 fusion gene expression in children with acute lymphoblastic leukemia after allogeneic hematopoietic stem cell transplantation].
    Hong Y; Qin YZ; Xu YY; Zhou SH; Wang Y; Xu LP; Zhang XH; Huang XJ; Zhao XS
    Zhonghua Xue Ye Xue Za Zhi; 2017 Aug; 38(8):680-684. PubMed ID: 28954346
    [No Abstract]   [Full Text] [Related]  

  • 39. Prognostic impact of RUNX1 and ETV6 gene copy number on pediatric B-cell precursor acute lymphoblastic leukemia with or without hyperdiploidy.
    Kutlay NY; Pekpak E; Altıner S; Ileri T; Vicdan AN; Dinçaslan H; Ince EU; Tukun FA
    Int J Hematol; 2016 Sep; 104(3):368-77. PubMed ID: 27393278
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Clonal origins of ETV6-RUNX1⁺ acute lymphoblastic leukemia: studies in monozygotic twins.
    Alpar D; Wren D; Ermini L; Mansur MB; van Delft FW; Bateman CM; Titley I; Kearney L; Szczepanski T; Gonzalez D; Ford AM; Potter NE; Greaves M
    Leukemia; 2015 Apr; 29(4):839-46. PubMed ID: 25388957
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.